Aug 2026
Precision therapy reduces the risk of diabetes in people with cystic fibrosis-related diabetes
S. Atteih, K. Raraigh, M. Wu et al.
· medRxiv · 0 citations
2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Open access
Sep 2026
In Vitro Responsiveness of 417 CFTR Variants to Vanzacaftor/Tezacaftor/Ivacaftor.
The findings may inform people with cystic fibrosis and caregivers pursuing off-label access to modulator therapies when genotype-based eligibility is limited and highlight remaining variants that may require alternative therapeutic strategies.
H. Bihler, Andrey Sivachenko, Priyanka Bhatt et al.
· Journal of Cystic Fibrosis · 0 citations